794 related articles for article (PubMed ID: 12629639)
41. Epidemiological and clinical evaluation of hepatitis B, hepatitis C, and delta hepatitis viruses in Tajikistan.
Khan A; Kurbanov F; Tanaka Y; Elkady A; Sugiyama M; Dustov A; Mizokami M
J Med Virol; 2008 Feb; 80(2):268-76. PubMed ID: 18098133
[TBL] [Abstract][Full Text] [Related]
42. Role of hepatitis B virus genotype mixture, subgenotypes C2 and B2 on hepatocellular carcinoma: compared with chronic hepatitis B and asymptomatic carrier state in the same area.
Yin J; Zhang H; Li C; Gao C; He Y; Zhai Y; Zhang P; Xu L; Tan X; Chen J; Cheng S; Schaefer S; Cao G
Carcinogenesis; 2008 Sep; 29(9):1685-91. PubMed ID: 18192693
[TBL] [Abstract][Full Text] [Related]
43. [Serum anti-hepatitis C virus and hepatitis C virus RNA in patients with hepatocellular carcinoma].
Jiang MD
Zhonghua Yi Xue Za Zhi; 1993 Mar; 73(3):131-4, 189. PubMed ID: 7686810
[TBL] [Abstract][Full Text] [Related]
44. Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients.
Squadrito G; Pollicino T; Cacciola I; Caccamo G; Villari D; La Masa T; Restuccia T; Cucinotta E; Scisca C; Magazzu D; Raimondo G
Cancer; 2006 Mar; 106(6):1326-30. PubMed ID: 16453330
[TBL] [Abstract][Full Text] [Related]
45. The significance of hepatitis B virus DNA detected in hepatocellular carcinoma of patients with hepatitis C.
Shintani Y; Yotsuyanagi H; Moriya K; Fujie H; Tsutsumi T; Takayama T; Makuuchi M; Kimura S; Koike K
Cancer; 2000 Jun; 88(11):2478-86. PubMed ID: 10861423
[TBL] [Abstract][Full Text] [Related]
46. Virological analysis, genotypes and mutational patterns of the HBV precore/core gene in HBV/HCV-related hepatocellular carcinoma.
De Mitri MS; Cassini R; Morsica G; Bagaglio S; Andreone P; Loggi E; Muratori P; Bernardi M
J Viral Hepat; 2006 Sep; 13(9):574-81. PubMed ID: 16907843
[TBL] [Abstract][Full Text] [Related]
47. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
[TBL] [Abstract][Full Text] [Related]
48. Can the serological status of anti-HBc alone be considered a sentinel marker for detection of occult HBV infection?
Vitale F; Tramuto F; Orlando A; Vizzini G; Meli V; Cerame G; Mazzucco W; Virdone R; Palazzo U; Villafrate MR; Tagger A; Romano N
J Med Virol; 2008 Apr; 80(4):577-82. PubMed ID: 18297707
[TBL] [Abstract][Full Text] [Related]
49. Hepatitis gene chip in detecting HBV DNA, HCV RNA in serum and liver tissue samples of hepatitis patients.
Zhao W; Wan JM; Liu W; Liu QJ; Zhang L; Zhou ZX; Liu XJ; Zhang HR
Hepatobiliary Pancreat Dis Int; 2003 May; 2(2):234-41. PubMed ID: 14599976
[TBL] [Abstract][Full Text] [Related]
50. High prevalence of transfusion-transmitted virus among patients with non-B, non-C hepatocellular carcinoma.
Nakagawa N; Ikoma J; Ishihara T; Yasui N; Fujita N; Iwasa M; Kaito M; Watanabe S; Adachi Y
Cancer; 1999 Oct; 86(8):1437-40. PubMed ID: 10526270
[TBL] [Abstract][Full Text] [Related]
51. Influence of occult hepatitis B virus coinfection on the incidence of fibrosis and hepatocellular carcinoma in chronic hepatitis C.
Matsuoka S; Nirei K; Tamura A; Nakamura H; Matsumura H; Oshiro S; Arakawa Y; Yamagami H; Tanaka N; Moriyama M
Intervirology; 2008; 51(5):352-61. PubMed ID: 19127078
[TBL] [Abstract][Full Text] [Related]
52. HBsAg seroclearance in chronic hepatitis B in the Chinese: virological, histological, and clinical aspects.
Yuen MF; Wong DK; Sablon E; Tse E; Ng IO; Yuan HJ; Siu CW; Sander TJ; Bourne EJ; Hall JG; Condreay LD; Lai CL
Hepatology; 2004 Jun; 39(6):1694-701. PubMed ID: 15185311
[TBL] [Abstract][Full Text] [Related]
53. Molecular and serological evaluation of surface antigen negative hepatitis B virus infection in blood donors from Venezuela.
Gutiérrez C; Devesa M; Loureiro CL; León G; Liprandi F; Pujol FH
J Med Virol; 2004 Jun; 73(2):200-7. PubMed ID: 15122793
[TBL] [Abstract][Full Text] [Related]
54. Increasing incidence of hepatocellular carcinoma possibly associated with non-A, non-B hepatitis in Japan, disclosed by hepatitis B virus DNA analysis of surgically resected cases.
Sakamoto M; Hirohashi S; Tsuda H; Ino Y; Shimosato Y; Yamasaki S; Makuuchi M; Hasegawa H; Terada M; Hosoda Y
Cancer Res; 1988 Dec; 48(24 Pt 1):7294-7. PubMed ID: 2847867
[TBL] [Abstract][Full Text] [Related]
55. Frequent detection of hepatitis B virus DNA in hepatocellular carcinoma of patients with sustained virologic response for hepatitis C virus.
Tamori A; Hayashi T; Shinzaki M; Kobayashi S; Iwai S; Enomoto M; Morikawa H; Sakaguchi H; Shiomi S; Takemura S; Kubo S; Kawada N
J Med Virol; 2009 Jun; 81(6):1009-14. PubMed ID: 19382258
[TBL] [Abstract][Full Text] [Related]
56. Subclinical reactivation of hepatitis B virus in liver transplant recipients with past exposure.
Abdelmalek MF; Pasha TM; Zein NN; Persing DH; Wiesner RH; Douglas DD
Liver Transpl; 2003 Dec; 9(12):1253-7. PubMed ID: 14625824
[TBL] [Abstract][Full Text] [Related]
57. Distribution and hepatocellular carcinoma-related viral properties of hepatitis B virus genotypes in Mainland China: a community-based study.
Yin J; Zhang H; He Y; Xie J; Liu S; Chang W; Tan X; Gu C; Lu W; Wang H; Bi S; Cui F; Liang X; Schaefer S; Cao G
Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):777-86. PubMed ID: 20160279
[TBL] [Abstract][Full Text] [Related]
58. Hepatitis B infection of the liver in chronic hepatitis C without detectable hepatitis B virus DNA in serum.
Mariscal LF; Rodríguez-Iñigo E; Bartolomé J; Castillo I; Ortiz-Movilla N; Navacerrada C; Pardo M; Pérez-Mota A; Graus J; Carreño V
J Med Virol; 2004 Jun; 73(2):177-86. PubMed ID: 15122790
[TBL] [Abstract][Full Text] [Related]
59. Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy.
Sheng WH; Kao JH; Chen PJ; Huang LM; Chang SY; Sun HY; Hung CC; Chen MY; Chang SC
Clin Infect Dis; 2007 Nov; 45(9):1221-9. PubMed ID: 17918088
[TBL] [Abstract][Full Text] [Related]
60. Previous or occult hepatitis B virus infection in hepatitis B surface antigen-negative and anti-hepatitis C-negative patients with hepatocellular carcinoma.
Ohba K; Kubo S; Tamori A; Hirohashi K; Tanaka H; Shuto T; Nishiguchi S; Kinoshita H
Surg Today; 2004; 34(10):842-8. PubMed ID: 15449154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
